Trial Profile
Z-103 clinical pharmacological study--the effect of a single administration of Z-103 to subjects with zinc deficiency--
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Jun 2016
Price :
$35
*
At a glance
- Drugs Polaprezinc (Primary)
- Indications Gastric ulcer; Taste disorders
- Focus Pharmacokinetics
- Sponsors Zeria
- 03 Jun 2016 New trial record